Clari Vest Asset Management LLC Alnylam Pharmaceuticals, Inc. Transaction History

Clari Vest Asset Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 12, 2020	SELL	$104.21 - $156.44 $1.74 Million - $2.61 Million	-16,696 Reduced 99.98%	4 $1,000
Q1 2020 May 04, 2020	BUY	$93.12 - $133.99 $121,056 - $174,187	1,300 Added 8.44%	16,700 $1.82 Million
Q4 2019 Feb 12, 2020	SELL	$74.51 - $124.23 $37,255 - $62,115	-500 Reduced 3.14%	15,400 $1.77 Million
Q3 2019 Nov 12, 2019	SELL	$70.9 - $87.82 $14,180 - $17,564	-200 Reduced 1.24%	15,900 $1.28 Million
Q2 2019 Aug 16, 2019	SELL	$65.86 - $92.79 $6,586 - $9,279	-100 Reduced 0.62%	16,100 $1.17 Million
Q1 2019 May 13, 2019	SELL	$72.76 - $93.45 $29,104 - $37,380	-400 Reduced 2.41%	16,200 $1.51 Million
Q2 2018 Aug 10, 2018	SELL	$88.31 - $107.8 $256,099 - $312,620	-2,900 Reduced 14.87%	16,600 $1.64 Million
Q4 2017 Feb 13, 2018	BUY	$114.49 - $139.98 $2.23 Million - $2.73 Million	19,500	19,500 $2.48 Million

666

112M

839K

771K

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $30.8B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Clari Vest Asset Management LLC with notifications on news.